Jane Street Group, LLC Adma Biologics, Inc. Put Options Transaction History

Jane Street Group, LLC

  • $616 Billion
  • Q3 2025

Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$14.66 - $19.91 $1.49 Million - $2.02 Million
101,300 Added 197.47%
152,600 $2.24 Million
Q2 2025

Aug 14, 2025
BUY
$17.6 - $24.51 $316,800 - $441,180
18,000 Added 54.05%
51,300 $934,000
Q1 2025

May 14, 2025
BUY
$15.44 - $20.61 $514,152 - $686,313
33,300 New
33,300 $660,000
Q4 2021

Feb 15, 2022
BUY
$1.09 - $1.66 $2,507 - $3,818
2,300 Added 11.27%
22,700 $32,000
Q3 2021

Nov 16, 2021
BUY
$1.13 - $1.65 $2,373 - $3,465
2,100 Added 11.48%
20,400 $23,000
Q2 2021

Aug 16, 2021
BUY
$1.51 - $2.07 $27,633 - $37,881
18,300 New
18,300 $29,000

Others Institutions Holding ADMA

# of Institutions
400
Shares Held
205M
Call Options Held
3.06M
Put Options Held
1.88M
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.06B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email